Eintrag weiter verarbeiten
Global Cancer in Women: Cancer Control Priorities
Gespeichert in:
| Zeitschriftentitel: | Cancer Epidemiology, Biomarkers & Prevention |
|---|---|
| Personen und Körperschaften: | , , , , |
| In: | Cancer Epidemiology, Biomarkers & Prevention, 26, 2017, 4, S. 458-470 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Association for Cancer Research (AACR)
|
| Schlagwörter: |
| author_facet |
Islami, Farhad Torre, Lindsey A. Drope, Jeffrey M. Ward, Elizabeth M. Jemal, Ahmedin Islami, Farhad Torre, Lindsey A. Drope, Jeffrey M. Ward, Elizabeth M. Jemal, Ahmedin |
|---|---|
| author |
Islami, Farhad Torre, Lindsey A. Drope, Jeffrey M. Ward, Elizabeth M. Jemal, Ahmedin |
| spellingShingle |
Islami, Farhad Torre, Lindsey A. Drope, Jeffrey M. Ward, Elizabeth M. Jemal, Ahmedin Cancer Epidemiology, Biomarkers & Prevention Global Cancer in Women: Cancer Control Priorities Oncology Epidemiology |
| author_sort |
islami, farhad |
| spelling |
Islami, Farhad Torre, Lindsey A. Drope, Jeffrey M. Ward, Elizabeth M. Jemal, Ahmedin 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-16-0871 <jats:title>Abstract</jats:title> <jats:p>This review is an abbreviated version of a report prepared for the American Cancer Society Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, which was released at the Union for International Cancer Control World Cancer Congress in Paris in November 2016. The original report can be found at https://www.cancer.org/health-care-professionals/our-global-health-work/global-cancer-burden/global-burden-of-cancer-in-women.html. Staff in the Intramural Research Department of the American Cancer Society designed and conducted the study, including analysis, interpretation, and presentation of the review. The funding sources had no involvement in the study design, data analysis and interpretation, or preparation of the review.</jats:p> <jats:p>The global burden of cancer in women has recently received much attention, but there are few comprehensive reviews of the burden and policy approaches to reduce it. This article, second in series of two, summarizes the most important cancer control priorities with specific examples of proven interventions, with a particular focus on primary prevention in low- and middle-income countries (LMIC). There are a number of effective cancer control measures available to countries of all resource levels. Many of these measures are extremely cost-effective, especially in the case of tobacco control and vaccination. Countries must prioritize efforts to reduce known cancer risk factors and make prevention accessible to all. Effective treatments and palliative care are also needed for those who develop cancer. Given scarce resources, this may seem infeasible in many LMICs, but past experience with other diseases like HIV, tuberculosis, and malaria have shown that it is possible to make affordable care accessible to all. Expansion of population-based cancer registries and research in LMICs are needed for setting cancer control priorities and for determining the most effective interventions. For LMICs, all of these activities require support and commitment from the global community. Cancer Epidemiol Biomarkers Prev; 26(4); 458–70. ©2017 AACR.</jats:p> <jats:p>See related article by Torre et al. in this CEBP Focus section, “Global Cancer in Women.”</jats:p> Global Cancer in Women: Cancer Control Priorities Cancer Epidemiology, Biomarkers & Prevention |
| doi_str_mv |
10.1158/1055-9965.epi-16-0871 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE2LTA4NzE |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE2LTA4NzE |
| institution |
DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Zi4 DE-Gla1 DE-15 DE-Pl11 DE-Rs1 DE-14 DE-105 DE-Ch1 DE-L229 |
| imprint |
American Association for Cancer Research (AACR), 2017 |
| imprint_str_mv |
American Association for Cancer Research (AACR), 2017 |
| issn |
1055-9965 1538-7755 |
| issn_str_mv |
1055-9965 1538-7755 |
| language |
English |
| mega_collection |
American Association for Cancer Research (AACR) (CrossRef) |
| match_str |
islami2017globalcancerinwomencancercontrolpriorities |
| publishDateSort |
2017 |
| publisher |
American Association for Cancer Research (AACR) |
| recordtype |
ai |
| record_format |
ai |
| series |
Cancer Epidemiology, Biomarkers & Prevention |
| source_id |
49 |
| title |
Global Cancer in Women: Cancer Control Priorities |
| title_unstemmed |
Global Cancer in Women: Cancer Control Priorities |
| title_full |
Global Cancer in Women: Cancer Control Priorities |
| title_fullStr |
Global Cancer in Women: Cancer Control Priorities |
| title_full_unstemmed |
Global Cancer in Women: Cancer Control Priorities |
| title_short |
Global Cancer in Women: Cancer Control Priorities |
| title_sort |
global cancer in women: cancer control priorities |
| topic |
Oncology Epidemiology |
| url |
http://dx.doi.org/10.1158/1055-9965.epi-16-0871 |
| publishDate |
2017 |
| physical |
458-470 |
| description |
<jats:title>Abstract</jats:title>
<jats:p>This review is an abbreviated version of a report prepared for the American Cancer Society Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, which was released at the Union for International Cancer Control World Cancer Congress in Paris in November 2016. The original report can be found at https://www.cancer.org/health-care-professionals/our-global-health-work/global-cancer-burden/global-burden-of-cancer-in-women.html. Staff in the Intramural Research Department of the American Cancer Society designed and conducted the study, including analysis, interpretation, and presentation of the review. The funding sources had no involvement in the study design, data analysis and interpretation, or preparation of the review.</jats:p>
<jats:p>The global burden of cancer in women has recently received much attention, but there are few comprehensive reviews of the burden and policy approaches to reduce it. This article, second in series of two, summarizes the most important cancer control priorities with specific examples of proven interventions, with a particular focus on primary prevention in low- and middle-income countries (LMIC). There are a number of effective cancer control measures available to countries of all resource levels. Many of these measures are extremely cost-effective, especially in the case of tobacco control and vaccination. Countries must prioritize efforts to reduce known cancer risk factors and make prevention accessible to all. Effective treatments and palliative care are also needed for those who develop cancer. Given scarce resources, this may seem infeasible in many LMICs, but past experience with other diseases like HIV, tuberculosis, and malaria have shown that it is possible to make affordable care accessible to all. Expansion of population-based cancer registries and research in LMICs are needed for setting cancer control priorities and for determining the most effective interventions. For LMICs, all of these activities require support and commitment from the global community. Cancer Epidemiol Biomarkers Prev; 26(4); 458–70. ©2017 AACR.</jats:p>
<jats:p>See related article by Torre et al. in this CEBP Focus section, “Global Cancer in Women.”</jats:p> |
| container_issue |
4 |
| container_start_page |
458 |
| container_title |
Cancer Epidemiology, Biomarkers & Prevention |
| container_volume |
26 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792335833324322823 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T14:50:50.287Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Global+Cancer+in+Women%3A+Cancer+Control+Priorities&rft.date=2017-04-01&genre=article&issn=1538-7755&volume=26&issue=4&spage=458&epage=470&pages=458-470&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=Global+Cancer+in+Women%3A+Cancer+Control+Priorities&aulast=Jemal&aufirst=Ahmedin&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-16-0871&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792335833324322823 |
| author | Islami, Farhad, Torre, Lindsey A., Drope, Jeffrey M., Ward, Elizabeth M., Jemal, Ahmedin |
| author_facet | Islami, Farhad, Torre, Lindsey A., Drope, Jeffrey M., Ward, Elizabeth M., Jemal, Ahmedin, Islami, Farhad, Torre, Lindsey A., Drope, Jeffrey M., Ward, Elizabeth M., Jemal, Ahmedin |
| author_sort | islami, farhad |
| container_issue | 4 |
| container_start_page | 458 |
| container_title | Cancer Epidemiology, Biomarkers & Prevention |
| container_volume | 26 |
| description | <jats:title>Abstract</jats:title> <jats:p>This review is an abbreviated version of a report prepared for the American Cancer Society Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, which was released at the Union for International Cancer Control World Cancer Congress in Paris in November 2016. The original report can be found at https://www.cancer.org/health-care-professionals/our-global-health-work/global-cancer-burden/global-burden-of-cancer-in-women.html. Staff in the Intramural Research Department of the American Cancer Society designed and conducted the study, including analysis, interpretation, and presentation of the review. The funding sources had no involvement in the study design, data analysis and interpretation, or preparation of the review.</jats:p> <jats:p>The global burden of cancer in women has recently received much attention, but there are few comprehensive reviews of the burden and policy approaches to reduce it. This article, second in series of two, summarizes the most important cancer control priorities with specific examples of proven interventions, with a particular focus on primary prevention in low- and middle-income countries (LMIC). There are a number of effective cancer control measures available to countries of all resource levels. Many of these measures are extremely cost-effective, especially in the case of tobacco control and vaccination. Countries must prioritize efforts to reduce known cancer risk factors and make prevention accessible to all. Effective treatments and palliative care are also needed for those who develop cancer. Given scarce resources, this may seem infeasible in many LMICs, but past experience with other diseases like HIV, tuberculosis, and malaria have shown that it is possible to make affordable care accessible to all. Expansion of population-based cancer registries and research in LMICs are needed for setting cancer control priorities and for determining the most effective interventions. For LMICs, all of these activities require support and commitment from the global community. Cancer Epidemiol Biomarkers Prev; 26(4); 458–70. ©2017 AACR.</jats:p> <jats:p>See related article by Torre et al. in this CEBP Focus section, “Global Cancer in Women.”</jats:p> |
| doi_str_mv | 10.1158/1055-9965.epi-16-0871 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTE2LTA4NzE |
| imprint | American Association for Cancer Research (AACR), 2017 |
| imprint_str_mv | American Association for Cancer Research (AACR), 2017 |
| institution | DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Zi4, DE-Gla1, DE-15, DE-Pl11, DE-Rs1, DE-14, DE-105, DE-Ch1, DE-L229 |
| issn | 1055-9965, 1538-7755 |
| issn_str_mv | 1055-9965, 1538-7755 |
| language | English |
| last_indexed | 2024-03-01T14:50:50.287Z |
| match_str | islami2017globalcancerinwomencancercontrolpriorities |
| mega_collection | American Association for Cancer Research (AACR) (CrossRef) |
| physical | 458-470 |
| publishDate | 2017 |
| publishDateSort | 2017 |
| publisher | American Association for Cancer Research (AACR) |
| record_format | ai |
| recordtype | ai |
| series | Cancer Epidemiology, Biomarkers & Prevention |
| source_id | 49 |
| spelling | Islami, Farhad Torre, Lindsey A. Drope, Jeffrey M. Ward, Elizabeth M. Jemal, Ahmedin 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-16-0871 <jats:title>Abstract</jats:title> <jats:p>This review is an abbreviated version of a report prepared for the American Cancer Society Global Health department and EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, which was released at the Union for International Cancer Control World Cancer Congress in Paris in November 2016. The original report can be found at https://www.cancer.org/health-care-professionals/our-global-health-work/global-cancer-burden/global-burden-of-cancer-in-women.html. Staff in the Intramural Research Department of the American Cancer Society designed and conducted the study, including analysis, interpretation, and presentation of the review. The funding sources had no involvement in the study design, data analysis and interpretation, or preparation of the review.</jats:p> <jats:p>The global burden of cancer in women has recently received much attention, but there are few comprehensive reviews of the burden and policy approaches to reduce it. This article, second in series of two, summarizes the most important cancer control priorities with specific examples of proven interventions, with a particular focus on primary prevention in low- and middle-income countries (LMIC). There are a number of effective cancer control measures available to countries of all resource levels. Many of these measures are extremely cost-effective, especially in the case of tobacco control and vaccination. Countries must prioritize efforts to reduce known cancer risk factors and make prevention accessible to all. Effective treatments and palliative care are also needed for those who develop cancer. Given scarce resources, this may seem infeasible in many LMICs, but past experience with other diseases like HIV, tuberculosis, and malaria have shown that it is possible to make affordable care accessible to all. Expansion of population-based cancer registries and research in LMICs are needed for setting cancer control priorities and for determining the most effective interventions. For LMICs, all of these activities require support and commitment from the global community. Cancer Epidemiol Biomarkers Prev; 26(4); 458–70. ©2017 AACR.</jats:p> <jats:p>See related article by Torre et al. in this CEBP Focus section, “Global Cancer in Women.”</jats:p> Global Cancer in Women: Cancer Control Priorities Cancer Epidemiology, Biomarkers & Prevention |
| spellingShingle | Islami, Farhad, Torre, Lindsey A., Drope, Jeffrey M., Ward, Elizabeth M., Jemal, Ahmedin, Cancer Epidemiology, Biomarkers & Prevention, Global Cancer in Women: Cancer Control Priorities, Oncology, Epidemiology |
| title | Global Cancer in Women: Cancer Control Priorities |
| title_full | Global Cancer in Women: Cancer Control Priorities |
| title_fullStr | Global Cancer in Women: Cancer Control Priorities |
| title_full_unstemmed | Global Cancer in Women: Cancer Control Priorities |
| title_short | Global Cancer in Women: Cancer Control Priorities |
| title_sort | global cancer in women: cancer control priorities |
| title_unstemmed | Global Cancer in Women: Cancer Control Priorities |
| topic | Oncology, Epidemiology |
| url | http://dx.doi.org/10.1158/1055-9965.epi-16-0871 |